Axogen announced that Michael Dale is appointed as chief executive officer and as a member of the Axogen Board of Directors effective August 9, 2024. He succeeds Karen Zaderej, who will remain in an advisory role for nine months. Axogen has also named Paul Thomas as Chairman of the Board of Directors, effective August 9, 2024. Paul has served as a member of the Board since 2020 and has over 30 years of leadership experience in the healthcare industry.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AXGN:
- AxoGen Updates Corporate Presentation for Stakeholders
- Axogen, Inc. Announces New Leadership Appointments
- Is AXGN a Buy, Before Earnings?
- Axogen, Inc. to Report Second Quarter 2024 Financial Results and Host Conference Call on August 8, 2024
- AxoGen reports inducement grants under Nasdaq listing rule
Questions or Comments about the article? Write to editor@tipranks.com